Working safely at animal biosafety levels 3 and 4: Facility design implications

Lab Animal

Volumn 26, Issue 4, 1997, Pages 28-35

  Richmond, Jonathan Y ^a   Ruble, David L ^b   Brown, Bobby ^a   Jaax, Gerald P ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 3242794864     PISSN: 00937355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Hantavirus infection-Southwestern United States: Interim recommendations for risk reduction. MMWR; 42:RR-11, 1993.
2. CDC. Laboratory management of agents associated with Hantavirus Pulmonary Syndrome: Interim biosafety guidelines. MMWR; 43:RR-7, 1994.
3. CDC/NIH. Biosafety in Microbiological and Biomedical Laboratories, 3rd edition. HHS Publication No (CDC) 93-8395, 1993.
4. Richmond, J.Y. Arambulo, P., and Ruiz, A.M. Protection from risk in animal studies. Lab Animal; 22(2):36-39, 1993.
5. Richmond, J.Y. Hazard reduction in animal research facilities. Lab Animal; 20(2):23-29, 1991.
6. NIH. Guide for the Care and Use of Laboratory Animals. HEW Publication No. (NIH) 96-23, 1996.
7. USDA, Laboratory Animal Welfare Regulations, CFR, Subchapter. A, Parts 1, 2, and 3.